Anzeige
Mehr »
Dienstag, 30.06.2026 - Börsentäglich über 12.000 News
China kontrolliert Seltene Erden - Brasilien könnte die Antwort sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
337 Leser
Artikel bewerten:
(2)

TekniPlex Healthcare to Present Recyclable Blister Packaging Solutions at The Pharma Days 2026

The presentation will examine PPWR minimization-driven blister innovations, including recyclable and recycled pharmaceutical grades. Company will also showcase its advanced barrier materials and expanded multidose vial capabilities

Wayne, PA, May 13, 2026 (GLOBE NEWSWIRE) -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will exhibit and present at The Pharma Days 2026, taking place May 27-28 at Palexpo in Geneva, Switzerland. At Stand C1 in Hall 3, the company will feature its latest sustainability-driven innovations for primary pharmaceutical packaging, advanced barrier materials, and expanded injection blow molding capacity for multidose vial applications.

On May 28 at 10:20 a.m. in the TPSD Room, Robin Van Landeghem, Head of Strategic Innovation & Market Development at TekniPlex Healthcare, will deliver a presentation titled "Advancing Recyclable Polymer Solutions for Pharmaceutical Blister Packaging Under the PPWR Framework." The session will cover next-generation recyclable polymer structures, with a focus on patented polyester and polypropylene technologies. It will also address how the EU Packaging and Packaging Waste Regulation (PPWR) is reshaping requirements for pharmaceutical packaging. Although primary pharmaceutical packaging is exempt from PPWR's recyclability and minimum recycled-content rules when product quality is at stake, it remains subject to the regulation's mandatory minimization obligation, meaning that material and weight reduction principles still apply.

"PPWR is accelerating a fundamental shift in how the pharmaceutical industry approaches primary packaging," said Van Landeghem. "Recyclability and material reduction are no longer aspirational. They are converging into the baseline expectation for blister formats. TekniPlex Healthcare's role is to give pharmaceutical companies the technical confidence and regulatory clarity to adopt next-generation polymer solutions without compromising on product protection or manufacturability."

Recyclable blister solutions across the moisture barrier spectrum

For applications requiring mid- to high-moisture barrier properties, TekniPlex Healthcare's Tekniflex COC thermoformable blister films, paired with barrier PP lidding films, are recyclable within the PP #5 waste stream. For drugs that require little to no moisture barrier, the company's thermoformable polyester films and push-through polyester lidding films are recyclable within the PETE #1 waste stream. In partnership with Alpek Polyester, TekniPlex Healthcare has also introduced a pharma-grade blister film containing 30% post-consumer recycled (PCR) content using a mass balance approach, designed for applications with minimal barrier requirements.

Advanced barrier laminates and coated film solutions

TekniPlex Healthcare will also feature its portfolio of advanced barrier solutions, including Aclar laminates and PFAS-free SBC PVDC-coated PVC structures, engineered to deliver strong protection against moisture and oxygen for drugs with demanding stability profiles.

Expanded injection blow molding capacity for multidose vial packaging

At its facility in Modena, Italy, TekniPlex Healthcare has added substantial injection blow molding capacity for multidose vial packaging, supporting a wide range of pharmaceutical liquid applications, including the growing ophthalmic segment. Standard bottles range from 5-30 ml, including a 10 ml squeezable container designed specifically for Aptar Pharma's Ophthalmic Squeeze Dispenser (OSD) technology platform, that serves preservative-free multidose formulations in eye-care.
To learn more about TekniPlex Healthcare's latest materials science innovations, visit Stand C1 in Hall 3 at The Pharma Days 2026 or visit www.tekni-plex.com/healthcare.

About TekniPlex Healthcare

TekniPlex Healthcare utilizes advanced materials science expertise and technologies to develop and deliver critical solutions for medical and diagnostic devices, drug delivery systems and sterile barrier healthcare packaging applications. With a global reach, the division's deep understanding of the greater pharmaceuticals and medical landscape helps it produce exemplary barrier properties for drugs and precision medical devices for interventional and therapeutic procedures. In the medical device niche, TekniPlex Healthcare embodies a comprehensive CDMO partner capable of servicing every stage of the product life cycle, from design and development through component manufacturing and final assembly. Throughout its broad purview, the division's ever-evolving portfolio helps meet demands for high-leverage medicines and mission-critical healthcare products that benefit care providers and patients.

Contact Info

Natalia Rivera
natalia.rivera@tekni-plex.com
+1 480-395-3130

Attachment

  • Blister

© 2026 GlobeNewswire (Europe)
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.